Bioaffinity Technologies Inc.
13F holders, Q2 2025 (June 30)17holders
6new positions
5sold out
$0.29avg. 13F price*
At the end of Q2 2025, 17 institutions reported holding Bioaffinity Technologies Inc. in their 13F filings, unchanged from Q1 2025. 6 opened new positions and 5 sold out. The largest holders were Geode Capital Management, LLC ($36K), Allworth Financial LP ($15K) and Vanguard Group Inc. ($12K).
- Company
- Bioaffinity Technologies Inc.
- CUSIP
- 09076W109
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $23K |
| Exits | 5 | $15K |
All 13F filers, Q1 2025 → Q2 2025: 100,819 shares bought and 197,020 shares sold, net −96,201 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Geode Capital Management, LLC | 0.00% | Add +5.7% | 125,459 | $36K |
| Allworth Financial LP | 0.00% | New | 53,734 | $15K |
| Vanguard Group Inc. | 0.00% | Reduce -77.0% | 40,642 | $12K |
| Captrust Financial Advisors | 0.00% | No change | 27,885 | $8K |
| IFP Advisors, Inc | 0.00% | Add +66.7% | 25,000 | $7K |
| State Street Corp. | 0.00% | No change | 17,600 | $5K |
| XTX Topco Ltd | 0.00% | Add +23.7% | 15,598 | $4K |
| StoneX Group Inc. | 0.00% | New | 15,206 | $4K |
| Northern Trust Corp. | 0.00% | No change | 13,662 | $4K |
| Creative Planning | 0.00% | No change | 12,095 | $3K |
| Sprott Inc. | 0.00% | New | 10,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.4% | 3,128 | $898 |
| Citigroup Inc. | 0.00% | New | 1,478 | $424 |
| Raymond James Financial Inc. | 0.00% | New | 500 | $144 |
| Bank of America Corp. | 0.00% | Add +132.9% | 205 | $58 |
| Morgan Stanley | 0.00% | Reduce -66.7% | 100 | $29 |
| UBS Group AG | 0.00% | New | 24 | $7 |
"% of holder's portfolio" is BIOAFFINITY TECHNOLOGIES INC's weight in each manager's 13F, not the share of Bioaffinity Technologies Inc. the manager owns.